Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Antiprotozoal injectable solution.
COMPOSITION:
Each mL of injectable solution contains:
Imidocarb dipropionate 121.15 mg (equivalent to 85 mg of Imidocarb)
Excipients q.s.
INDICATIONS:
For the treatment of babesiosis in cattle (Babesia bovis, Babesia bigemina), horses (Babesia equi, Babesia caballi), and dogs (Babesia canis).
For the treatment of anaplasmosis in cattle (Anaplasma marginale).
DOSAGE AND ADMINISTRATION:
Cattle:
Babesiosis: 1.2 mg/kg (1.4 mL/100 kg) SC, single dose
Anaplasmosis: 2.1 mg/kg (2.5 mL/100 kg) SC, single dose
Babesiosis/Anaplasmosis: 2.1 mg/kg (2.5 mL/100 kg) SC, single dose
Maximum volume per injection site: 6 mL
Horses:
Babesia caballi: 2 mg/kg (2.4 mL/100 kg) IM, once daily for 2 consecutive days
Babesia equi: 4 mg/kg (4.7 mL/100 kg) IM, 4–5 injections at 72-hour intervals
Dogs:
Babesiosis: 5 mg/kg (0.5 mL/10 kg) SC or IM, repeat after 14 days
INTERACTIONS:
Avoid use in animals exposed to organophosphates, carbamates, insecticides, or other chemical agents.
PRECAUTIONS:
Transient cholinergic signs may occur and can be treated with atropine.
Dogs should be observed for 15 minutes after injection.
Use with caution in dogs with hepatic or renal insufficiency.
Store below 30°C, protected from light.
Keep out of reach of children and animals.
Veterinary prescription only.
CONTRAINDICATIONS:
Do not administer intravenously.
Do not use in horses under 1 year of age.
Do not use in animals with known hypersensitivity to the active ingredient or excipients.
Donkeys may be more sensitive to toxic effects.
WITHDRAWAL PERIOD:
Animals must not be slaughtered for human consumption until 213 days after the end of treatment.
Milk produced during treatment and for 6 days after must not be used for human consumption.
PRESENTATION:
Injectable solution.
USE IN: Cattle, horses, and dogs.
Antiprotozoal injectable solution.
COMPOSITION:
Each mL of injectable solution contains:
Imidocarb dipropionate 121.15 mg (equivalent to 85 mg of Imidocarb)
Excipients q.s.
INDICATIONS:
For the treatment of babesiosis in cattle (Babesia bovis, Babesia bigemina), horses (Babesia equi, Babesia caballi), and dogs (Babesia canis).
For the treatment of anaplasmosis in cattle (Anaplasma marginale).
DOSAGE AND ADMINISTRATION:
Cattle:
Babesiosis: 1.2 mg/kg (1.4 mL/100 kg) SC, single dose
Anaplasmosis: 2.1 mg/kg (2.5 mL/100 kg) SC, single dose
Babesiosis/Anaplasmosis: 2.1 mg/kg (2.5 mL/100 kg) SC, single dose
Maximum volume per injection site: 6 mL
Horses:
Babesia caballi: 2 mg/kg (2.4 mL/100 kg) IM, once daily for 2 consecutive days
Babesia equi: 4 mg/kg (4.7 mL/100 kg) IM, 4–5 injections at 72-hour intervals
Dogs:
Babesiosis: 5 mg/kg (0.5 mL/10 kg) SC or IM, repeat after 14 days
INTERACTIONS:
Avoid use in animals exposed to organophosphates, carbamates, insecticides, or other chemical agents.
PRECAUTIONS:
Transient cholinergic signs may occur and can be treated with atropine.
Dogs should be observed for 15 minutes after injection.
Use with caution in dogs with hepatic or renal insufficiency.
Store below 30°C, protected from light.
Keep out of reach of children and animals.
Veterinary prescription only.
CONTRAINDICATIONS:
Do not administer intravenously.
Do not use in horses under 1 year of age.
Do not use in animals with known hypersensitivity to the active ingredient or excipients.
Donkeys may be more sensitive to toxic effects.
WITHDRAWAL PERIOD:
Animals must not be slaughtered for human consumption until 213 days after the end of treatment.
Milk produced during treatment and for 6 days after must not be used for human consumption.
PRESENTATION:
Injectable solution.
USE IN: Cattle, horses, and dogs.
